DEPLOYDatabase

Robot model

da Vinci (and Ion)

surgicalproductionby Intuitive Surgical

Intuitive Surgical (NASDAQ: ISRG; founded 1995, Sunnyvale, California) is the dominant incumbent and verified gold standard of surgical robotics.

Track da Vinci (and Ion)
Manufacturer
Intuitive Surgical
Form factor
surgical
Maturity
production
Lifecycle
active
Deployments
15

The verified answer

As of Oct 2026, DEPLOY verifies da Vinci (and Ion), a surgical by Intuitive Surgical (production): 15 verified deployments on record. 6 sources back the record.

Regulatory status3 FDA 510(k) clearances6 FDA recalls1 FDA warning letter

da Vinci (and Ion) holds 3 FDA 510(k) clearances and has 6 FDA recalls and 1 FDA warning letter on record, per the DEPLOY registry.

See all 10 filings

Overview

Intuitive Surgical (NASDAQ: ISRG; founded 1995, Sunnyvale, California) is the dominant incumbent and verified gold standard of surgical robotics. Its da Vinci platform spans the multi-port X and Xi systems, the SP single-port system, and the fifth-generation da Vinci 5, which the FDA cleared via 510(k) on March 14, 2024 with a headline Force Feedback sensing feature, alongside the Ion endoluminal robotic bronchoscopy system cleared in February 2019.

As of its SEC Form 10-Q for the quarter ended March 31, 2026, the verified installed base was 11,395 da Vinci systems, up 12 percent year over year and including 1,464 da Vinci 5 units, plus 1,041 Ion systems, up 22 percent, with worldwide procedures growing about 17 percent. Surgical robotics sits in the registry as a deliberate axis-extension: physical AI operating in the medical regulatory regime, where FDA clearance is the verified gating event for maturity, and Intuitive clears it across multiple platforms and generations, placing it at production maturity.

On AI substance, da Vinci is a master-slave teleoperated system with shipped analytics-grade AI such as Case Insights and machine-vision interface features, and Force Feedback is a shipped sensing feature rather than autonomy; autonomous suturing and tissue manipulation via vision-language models are research demonstrations on da Vinci hardware, not shipped features, and the 4,000-mile telesurgery demonstration is investigational. The widely cited 43-percent-less-force figure is preclinical and marketing-sourced rather than an outcomes-verified clinical result.

Verified vs. claimed

Maturity stage
production(Full-scale production deployment with repeat customers.)
Sources on file
View all sources →

Key facts

Installed base (SEC filing, Mar 2026)

11,395 da Vinci systems as of Mar 31 2026.

Q1 2026 placements (company-reported)

431 da Vinci systems placed in Q1 2026, 232 of them da Vinci 5.

2025 placements (company-reported)

1,721 systems placed in 2025.

Autonomy level

Teleoperated (master-slave), with shipped analytics AI such as Case Insights. Force Feedback is sensing, not autonomy.

Form factor

Teleoperated multi-port and single-port surgical systems, plus endoluminal robotic bronchoscopy.

FDA clearance

da Vinci 5 received FDA 510(k) clearance on March 14, 2024; Ion was cleared in February 2019.

System price (reported)

da Vinci Xi about $1.5M; da Vinci 5 $1.8-2.5M, per Forbes, the ACS Bulletin and analyst estimates.

Per-procedure cost (reported)

$700-$3,200 per procedure in disposable instruments and accessories; replacement parts average about $1,900 per operation.

EndoWrist instruments

Disposable wristed forceps, scissors, needle drivers, scalpels and electrocautery tools, limited to 10 uses; about $2,300 per 10-use device.

Accessory prices (company price list, 2023)

Cannulas $630-683, arm drapes $378-1092 and stapler reloads $2,898.

Service contract (reported)

$100K-$175K per system per year.

Revenue (FY2025)

$10.06B: instruments and accessories $6.02B (60%), systems $2.47B (24%) and services $1.57B (16%).

Recurring revenue model

Disposables drive the economics: about $1,900 per procedure x 300 procedures a year is about $570K a year per installed system.

Gross margin (company-reported)

Non-GAAP gross margin of 69.1% in 2024, guided to 65-66.5% for 2025; GAAP gross profit of $6.64B on $10.06B revenue in 2025.

Procedure volume (company-reported, 2025)

3.1M+ da Vinci procedures in 2025 (+18% YoY), 20M+ cumulative, and 300+ per system per year on average.

Arms and motors

A patient-side cart with 3-4 arms; 30+ maxon DC motors per system (RE 25, RE 13 with GP 13 gearheads, RE 35) with magnetic encoders.

maxon motors (supplier-stated)

Swiss maxon's ironless-rotor, rare-earth-magnet motors give zero cogging; 10,000+ are in daily deployment.

Vision system

3D HD endoscope; da Vinci 5 has 4x the pixel resolution of Xi, 785nm Firefly fluorescence imaging and a tip heater for anti-fog.

Endoscope and imaging parts (2023 price list)

The endoscope lists at about $25,000; the system also uses camera control units, image synchronizers and high-intensity illuminators.

Surgeon console

Dual master manipulators with maxon motors, haptic feedback (Force Feedback on da Vinci 5) and a 3D stereoscopic viewer.

da Vinci 5 upgrades (company-stated)

About 150 design innovations and 10,000x the computing power of Xi.

Manufacturing

Vertically integrated design, assembly and testing at the Sunnyvale, CA campus (1050 Kifer Rd), with manufacturing and supply chain expanding.

Specs

Dof

7

Notes

Verified (production anchor): Intuitive Surgical (NASDAQ: ISRG; founded 1995, Sunnyvale CA) is the dominant incumbent and the verified gold standard. VERIFIED installed base (SEC 10-Q, 3/31/2026): 11,395 da Vinci systems (+12% YoY), of which 1,464 are da Vinci 5; plus 1,041 Ion systems (+22% YoY). Q1 2026 procedures +17% worldwide; 431 da Vinci placed (232 of them da Vinci 5). da Vinci 5 FDA-cleared Mar 14 2024; Ion FDA-cleared Feb 2019., Axis-extension framing: Surgical robotics is physical AI operating in the MEDICAL regulatory regime. FDA clearance is the verified gating event for maturity. Intuitive clears it across multiple platforms + generations -> production., AI-substance: teleop baseline + shipped analytics AI; autonomy demo-only: da Vinci is master-slave teleoperated. SHIPPED AI: Case Insights (AI analysis of system/kinematics/video for surgeon performance) and machine-vision interface features; Force Feedback is a shipped sensing feature (not autonomy). Autonomous suturing/tissue-lifting via VLMs (Johns Hopkins/Stanford) are RESEARCH demonstrations on da Vinci hardware, NOT shipped. 4,000-mile telesurgery is investigational/in-development., Claimed but NOT verified: '43% less force' is a preclinical/marketing figure, not an outcomes-verified clinical result. The 1,464 da Vinci 5 subfigure is company-reported (corroborated, model-level breakout).

Products

da Vinci multi-port (X / Xi), da Vinci SP single-port, da Vinci 5 (5th-gen, FDA 510(k) Mar 14 2024, Force Feedback), and Ion endoluminal robotic bronchoscopy (FDA Feb 2019).

Height cm

175.3

Weight kg

544

Form Factor

surgical (teleoperated master-slave multi-port + single-port surgical robot; + endoluminal robotic bronchoscopy)

Fda clearance

da Vinci 5 FDA 510(k) cleared March 14, 2024; Ion FDA cleared February 2019

Clearance body

FDA

To scale

Human175 cmda Vinci (and Ion)175.3 cm (5'9") · 544 kg

Data & sources

Company filings

2

Press releases

1

News coverage

1

Web sources

2

6 sources backing this record.View all →

Availability and pricing

Availability
Not sold (internal use)
Price
$1.8M to $2.5M (analyst estimate)as of 2024-03-01
Units in field
Not disclosed
Sales model
Not disclosed
Lead time
Not disclosed

Autonomy: verified vs claimed

What it actually does
Teleoperated (human-controlled)

Pricing

One-time purchase

$1,800,000 - $2,500,000 USDanalyst estimateas of 2024-03-01

Source: How Much is a Surgical Robot? (2025 Edition) — R2 Surgical / MassDEVICE da Vinci 5 launch

History

Price status: actual-sale-price = real published price at time of sale; manufacturer-target = vendor target, not yet realized; analyst-estimate = third-party projection, not a vendor figure; not-announced = no price on record.

Prices verified as of Jan 1, 2023

Deployments (15)

See all 15 deployments →

Free to use on your site, with a link back to DEPLOY.

da Vinci (and Ion) on the deployment map

View the global map

Where da Vinci (and Ion) is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Deployment-verified media (1)

PRIMARY SOURCE
Courtesy of Intuitive Surgical

Intuitive's introduction of its da Vinci 5 robotic surgical system. The da Vinci is teleoperated by a surgeon from a console, not autonomous.

From deployment: United States

Manufacturer-attributed media (3)

Manufacturer-supplied media at the model level. Not tied to an independently verified named-site deployment. Verification posture is product-showcase from the maker, distinct from the deployment-verified evidence in the section above.

PRIMARY SOURCE
Courtesy of Intuitive Surgical

Intuitive Surgical's look at single-incision surgery with the da Vinci SP single-port system. Surgeon-controlled from a master console, never autonomous; the single-incision indications are the SP's cleared procedures.

PRIMARY SOURCE
Courtesy of Intuitive Surgical

Intuitive Surgical's overview of the da Vinci SP single-port system, which passes three wristed instruments and a camera through a single cannula. Surgeon-teleoperated, never autonomous.

PRIMARY SOURCE
Courtesy of Intuitive Surgical

Intuitive Surgical's introduction of the da Vinci Xi, a multi-port surgeon-teleoperated robotic surgery system. A surgeon operates it from a master console; it is never autonomous.

Supply chain (1)

Actuators & motors

  • Harmonic DriveHarmonic Drive strain-wave gearboxes -- EndoWrist instrument wrist joints and robotic arm transmissionssupplies

Suppliers appear here when verified with at least two strong sources (maker-official / IR / regulatory / standards-body / verified tier-2). Sources are append-only; corrections add new sources rather than rewrite history.

Components (2)

  • da Vinci SureForm Stapleractuatorsafety-critical(primary safety)

    SureForm stapling instrument

    • mechanical wear · serious: FDA recall; lot removal and inspection of affected reloads.
    • other · catastrophic: FDA recall after a reload defect linked to a patient death; device correction.
  • da Vinci Instrument Armactuatorsafety-critical(primary safety)

    Instrument arm

    • software fault · serious: FDA recall; software implementation-error correction.

Components carry componentClass + safetyCritical flag. ModelComponent rows carry safety_role (primary_safety / backup_safety / monitoring / non_safety) + optional supplier identity.

Regulatory filings (10)

Safety record

47 recalls and 9 incidents on record (2 catastrophic, 4 critical, 39 serious, 9 moderate, 2 minor). Most recent: Jun 2026.

catastrophic
2
critical
4
serious
39
moderate
9
minor
2
recall
47
regulatory action
4
other
2
injury
2
fatality
1

Most recent: Jun 2026

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Incidents affecting da Vinci (and Ion) (56)

Includes incidents linked directly to this model or to deployments of it. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Sources (6)

  1. https://www.sec.gov/Archives/edgar/data/0001035267/000103526726000032/isrg-20260331.htm
  2. https://www.sec.gov/Archives/edgar/data/1035267/000103526726000029/q126ex-991earningsrelease.htm
  3. https://www.globenewswire.com/news-release/2024/03/14/2846718/7637/en/Intuitive-Announces-FDA-Clearance-of-Fifth-Generation-Robotic-System-da-Vinci-5.html
  4. https://www.therobotreport.com/intuitive-demos-4000-mile-telesurgery-with-da-vinci-5-surgical-robot/
  5. https://www.fiercebiotech.com/medtech/intuitive-launches-latest-da-vinci-robot-force-feedback-controls
  6. https://robotsguide.com/robots/davinci

Compare da Vinci (and Ion)

Mentioned on (2+)

Registry pages whose text names da Vinci (and Ion).

About 8 more pages name da Vinci (and Ion) and were not checked here.

Common questions

What is da Vinci (and Ion)?
Intuitive Surgical (NASDAQ: ISRG; founded 1995, Sunnyvale, California) is the dominant incumbent and verified gold standard of surgical robotics. Its da Vinci platform spans the multi-port X and Xi systems, the SP single-port system, and the fifth-generation da Vinci 5, which the FDA cleared via 510(k) on March 14, 2024 with a headline Force Feedback sensing feature, alongside the Ion endoluminal robotic bronchoscopy system cleared in February 2019. As of its SEC Form 10-Q for the quarter ended March 31, 2026, the verified installed base was 11,395 da Vinci systems, up 12 percent year over year and including 1,464 da Vinci 5 units, plus 1,041 Ion systems, up 22 percent, with worldwide procedures growing about 17 percent. Surgical robotics sits in the registry as a deliberate axis-extension: physical AI operating in the medical regulatory regime, where FDA clearance is the verified gating event for maturity, and Intuitive clears it across multiple platforms and generations, placing it at production maturity. On AI substance, da Vinci is a master-slave teleoperated system with shipped analytics-grade AI such as Case Insights and machine-vision interface features, and Force Feedback is a shipped sensing feature rather than autonomy; autonomous suturing and tissue manipulation via vision-language models are research demonstrations on da Vinci hardware, not shipped features, and the 4,000-mile telesurgery demonstration is investigational. The widely cited 43-percent-less-force figure is preclinical and marketing-sourced rather than an outcomes-verified clinical result.
How much does da Vinci (and Ion) cost?
da Vinci (and Ion) is listed at $1,800,000 to $2,500,000 on the DEPLOY registry. This is an analyst estimate, not an official price.
How Much is a Surgical Robot? (2025 Edition) — R2 Surgical / MassDEVICE da Vinci 5 launch
Is da Vinci (and Ion) actually deployed in the real world?
Yes. da Vinci (and Ion) is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Is da Vinci (and Ion) autonomous or teleoperated?
Not verified as fully autonomous. da Vinci (and Ion)'s capabilities on the DEPLOY registry are recorded as teleoperated-assisted, demonstrated-only, or vendor claims (Assists surgery), not independently confirmed to run without a human in the loop.
What are the specs of da Vinci (and Ion)?
da Vinci (and Ion)'s recorded specifications on the DEPLOY registry: Degrees of freedom: 7; Height: 175.3 cm; Weight: 544 kg. See the Specs section for the full sourced set.
Who makes da Vinci (and Ion)?
da Vinci (and Ion) is made by Intuitive Surgical, based in Sunnyvale, California, USA, founded in 1995.
Where is da Vinci (and Ion) deployed?
15 verified deployments of da Vinci (and Ion) are on the DEPLOY registry, including at United States (multiple hotel chains), Global (multiple sites), Tampa, Florida, USA.
Can you buy da Vinci (and Ion)?
da Vinci (and Ion) is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
Is da Vinci (and Ion) FDA cleared?
da Vinci (and Ion) has 10 regulatory records on the DEPLOY registry: FDA recall (Z-1232-2026), recalled; FDA recall (Z-1262-2023), recalled; FDA recall (Z-0340-2023), recalled and 7 more. See the Regulatory filings section for each agency source.
What are alternatives to da Vinci (and Ion)?
On the DEPLOY registry, comparable surgical robots to da Vinci (and Ion) include Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics, Toumai.
How does da Vinci (and Ion) compare to Edge Multi-Port Surgical Robot?
da Vinci (and Ion) and Edge Multi-Port Surgical Robot (Edge Medical Robotics · 14 deployments) are both surgical robots on the DEPLOY registry. da Vinci (and Ion) has 15 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is da Vinci (and Ion) a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, da Vinci (and Ion) ranks in roughly the top under 1% of surgical models tracked by the registry.
What is da Vinci (and Ion)'s maturity stage?
da Vinci (and Ion) is at the production stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Production stage means high-volume manufacture and commercial-scale deployments are sustained.
Is da Vinci (and Ion) safe?
da Vinci (and Ion) has 56 active incidents on record in the DEPLOY registry. 47 recalls and 9 incidents on record (2 catastrophic, 4 critical, 39 serious, 9 moderate, 2 minor). Most recent: Jun 2026. Retracted incidents are excluded from this count.
How much does a da Vinci surgical robot cost?
The da Vinci Xi costs approximately $1.5 to $2.5 million. The latest da Vinci 5 ranges from $1.8 to $2.5 million. The entry-level da Vinci X costs $0.8 to $1.8 million. Annual maintenance fees total about 10% of the initial purchase price. The average selling price of a da Vinci Xi is approximately $1.42 million.
ACS Bulletin: Cost of Robotic Surgery R2Surgical: How Much is a Surgical Robot
Methodology: Verified · 6 sources (3 primary) · last reviewed 2026-10-10

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-10-10

Maturity + lifecycle

Maturity stage: production

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

2
primary-sec-filing
SEC filing
2
unclassified
Unclassified source
1
primary-company-ir
Company IR disclosure
1
secondary-trade-publication
Trade publication

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for da Vinci (and Ion).

Recent coverage

da Vinci (and Ion) in third-party press

WVU Medicine Princeton Community Hospital now using da Vinci 5 system for robotic surgery

Sep 21, 2026

Surgeons use da Vinci surgical robot to perform common cardiac surgery

Aug 17, 2026

PVHMC First in the Region to Introduce State-of-the-Art da Vinci 5 Surgical Robots

Aug 3, 2026